NCT03132545View on ClinicalTrials.gov

Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Polycystic Ovary Syndrome
Interventions
DIAGNOSTIC_TEST

SenseWear Armband (SWA) monitoring

Participants wore the SWA on their right arm

DIAGNOSTIC_TEST

total body dual-energy X-ray absorptiometry

DEXA was used to estimate abdominal visceral adipose tissue and subcutaneous adipose tissue

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03132545 - Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter